← All companies

VTRS

Viatris Inc.

VTRS Nasdaq Pharmaceutical Preparations EDGAR ↗

$17.63

-0.13 -0.73%

Key statistics

from XBRL data in SEC filings

Market cap

$20.5B

Revenue (TTM)

$14.5B

Net income (TTM)

-$297M

EPS (TTM)

$-0.30

P/E ratio

—

Dividend yield

2.72%

Free cash flow

$1.94B

Cash

$1.80B

Total assets

$36.8B

Gross margin

34.5%

52-week range

$8.74 – $18.07

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Took on a direct financial obligation Jul 1, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jun 18, 2026 8-K Other events Jun 15, 2026 8-K Shareholder vote results May 15, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Other events May 7, 2026 8-K Director or officer change; Regulation FD disclosure May 4, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Exit or disposal costs; Other events Feb 26, 2026 8-K Director or officer change Feb 3, 2026 8-K Regulation FD disclosure Dec 8, 2025 8-K Shareholder vote results Dec 5, 2025 8-K/A Director or officer change Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Other events Nov 6, 2025 8-K Amended charter or bylaws; Item 5.08; Other events Oct 24, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Other events Aug 7, 2025 8-K Director or officer change; Regulation FD disclosure Aug 5, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Other events May 8, 2025 8-K Director or officer change; Regulation FD disclosure May 5, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Other events Feb 27, 2025 8-K Director or officer change; Shareholder vote results Dec 6, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Other events Nov 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation Sep 27, 2024 8-K Regulation FD disclosure Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Other events Aug 8, 2024 8-K Completed an acquisition or disposition Jul 3, 2024 8-K Director or officer change; Regulation FD disclosure Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Other events May 9, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release); Other events Feb 28, 2024 8-K/A Entered a material agreement Jan 30, 2024